Carvedilol
- Product NDC
- 50090-5115
- 11-digit product format
- 500905115
- Labeler code
- 50090
- Product ID
- 50090-5115_835b01c6-d2bf-41a4-a96a-1a8077bddc3e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carvedilol
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076373
- Marketing category
- ANDA
- Marketing start
- 2007-09-06
- Marketing end
- 0000-00-00
- Substance
- CARVEDILOL
- Active strength
- 13 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 50090-5115 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 50090-5115 | 50090-5115-0 | I | Inactivated by FDA | 2026-08-03 | |
| excluded package | package | 50090-5115 | 50090-5115-1 | I | Inactivated by FDA | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076373-001 | CARVEDILOL | CARVEDILOL | 3.125MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-002 | CARVEDILOL | CARVEDILOL | 6.25MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-003 | CARVEDILOL | CARVEDILOL | 12.5MG | TABLET / ORAL | AB | 2007-09-05 | |
| A076373-004 | CARVEDILOL | CARVEDILOL | 25MG | TABLET / ORAL | AB | 2007-09-05 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A076373-001 | AB |
| A076373-002 | AB |
| A076373-003 | AB |
| A076373-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076373-001 | CARVEDILOL | 3.125MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-002 | CARVEDILOL | 6.25MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-003 | CARVEDILOL | 12.5MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A076373-004 | CARVEDILOL | 25MG | TABLET / ORAL | AB | 2007-09-05 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A076373-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A076373-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carvedilol | CARVEDILOL | A-S Medication Solutions | fe2d5c95-c101-4b01-89fd-0fd6d25ad80b | 2026-04-26 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | 8db9cddd-0ee7-4ce8-a8c9-c5e043b2838a | 2026-03-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | QPharma, Inc. | ffbedcce-0d64-4aed-9e65-09448d71ca91 | 2025-12-05 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | 52785a22-ddca-4f5b-8579-5974df2a9a4e | 2025-12-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | NCS HealthCare of KY, LLC dba Vangard Labs | 2fb46fe1-9b7b-4718-9327-2471af22f0b7 | 2025-06-11 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | da2696ba-f4be-4626-9abe-fe33f36361b1 | 2025-05-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Proficient Rx LP | c0202d0f-2ffc-45f2-a98d-5f05ac1eaa85 | 2025-02-01 | Warnings, Adverse reactions | 076373 ANDA076373 |
| Carvedilol | CARVEDILOL | Teva Pharmaceuticals USA, Inc. | 68c275e8-992a-4520-8065-ab6d615d89cc | 2024-03-25 | Warnings, Adverse reactions | 076373 ANDA076373 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e148a93c-bfff-2735-e6c0-0739297b4596 | Product name | 3 | 20180705 |
| 32d6365f-9f0e-0782-b719-48e651893fb7 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5115-0 | Carvedilol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 3 | |
| 50090-5115-1 | Carvedilol | 180 in 1 BOTTLE | TABLET, FILM COATED | 180 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5115 | CARVEDILOL TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210303_52a672a8-db98-4acf-99d5-62eb2977e767.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 200032 | carvedilol 12.5 MG Oral Tablet | PSN | 52a672a8-db98-4acf-99d5-62eb2977e767 | 3 |
| 200032 | carvedilol 12.5 MG Oral Tablet | SCD | 52a672a8-db98-4acf-99d5-62eb2977e767 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-5115-0 | 50090511500 | 60 TABLET, FILM COATED in 1 BOTTLE (50090-5115-0) | 2020-07-31 | 0000-00-00 | No | No | Current |
| 50090-5115-1 | 50090511501 | 180 TABLET, FILM COATED in 1 BOTTLE (50090-5115-1) | 2020-07-31 | 0000-00-00 | No | No | Current |